Skip to main content
SpringerLink
Log in

PRC2 loss amplifies Ras signaling in cancer

  • News & Views
  • Published:

From Nature Genetics

View current issue Submit your manuscript

The histone-modifying PRC2 complex has an ambiguous role in cancer, bearing both oncogenic and tumor-suppressive features depending on cell type. Studies of malignant peripheral nerve sheath tumors (MPNSTs) have now identified loss-of-function mutations altering PRC2 subunits, leading to the amplification of Ras-driven transcription and conferring vulnerability to BRD4 inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: PRC2 loss cooperates with Ras activation to drive tumor progression in MPNSTs.

Katie Vicari/Nature Publishing Group

References

  1. Di Croce, L. & Helin, K. Nat. Struct. Mol. Biol. 20, 1147–1155 (2013).

    Article  CAS  Google Scholar 

  2. Bracken, A.P. et al. EMBO J. 22, 5323–5335 (2003).

    Article  CAS  Google Scholar 

  3. Ernst, T. et al. Nat. Genet. 42, 722–726 (2010).

    Article  CAS  Google Scholar 

  4. Lee, W. et al. Nat. Genet. 46, 1227–1232 (2014).

    Article  CAS  Google Scholar 

  5. Zhang, M. et al. Nat. Genet. 46, 1170–1172 (2014).

    Article  CAS  Google Scholar 

  6. Basu, T.N. et al. Nature 356, 713–715 (1992).

    Article  CAS  Google Scholar 

  7. De Raedt, T. et al. Nature doi:10.1038/nature13561 (13 August 2014).

  8. Pasini, D. et al. Nucleic Acids Res. 38, 4958–4969 (2010).

    Article  CAS  Google Scholar 

  9. Filippakopoulos, P. et al. Cell 149, 214–231 (2012).

    Article  CAS  Google Scholar 

  10. Filippakopoulos, P. et al. Nature 468, 1067–1073 (2010).

    Article  CAS  Google Scholar 

  11. Jessen, W.J. et al. J. Clin. Invest. 123, 340–347 (2013).

    Article  CAS  Google Scholar 

  12. McCabe, M.T. & Creasy, C.L. Epigenomics 6, 341–351 (2014).

    Article  CAS  Google Scholar 

  13. Downward, J. Nat. Rev. Cancer 3, 11–22 (2003).

    Article  CAS  Google Scholar 

  14. Lewis, P.W. et al. Science 340, 857–861 (2013).

    Article  CAS  Google Scholar 

  15. Iliopoulos, D. et al. Mol. Cell 39, 761–772 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Annika Baude and Christoph Plass are in the Division of Epigenomics and Cancer Risk Factors at the German Cancer Research Center (DKFZ), Heidelberg, Germany.,

    Annika Baude & Christoph Plass

  2. Anders M. Lindroth is at the Graduate School of Cancer Science and Policy, National Cancer Center, Goyang-si, Republic of Korea.,

    Anders M Lindroth

Authors
  1. Annika Baude
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anders M Lindroth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christoph Plass
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Plass.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baude, A., Lindroth, A. & Plass, C. PRC2 loss amplifies Ras signaling in cancer. Nat Genet 46, 1154–1155 (2014). https://doi.org/10.1038/ng.3124

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.3124

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation